{{drugbox
| Verifiedfields = changed
| Watchedfields = changed
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 62M960DHIL| verifiedrevid = 376110842
| IUPAC_name = (''endo'')-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-propylpentanoate bromide
| image = Octatropine methylbromide.svg
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 80-50-2
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 6647
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00517
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1186610
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 10482228
| smiles            = CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C.[Br-]
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C17H32NO2.BrH/c1-5-7-13(8-6-2)17(19)20-16-11-14-9-10-15(12-16)18(14,3)4;/h13-16H,5-12H2,1-4H3;1H/q+1;/p-1/t14-,15+,16+;
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = QSFKGMJOKUZAJM-CNKDKAJDSA-M
| C=17 | H=32 | N=1 | O=2 | Br=1
| molecular_weight = 362.345 g/mol
| synonyms = 8-Methyltropinium bromide 2- propylvalerate
| bioavailability = 10 to 25% (oral)
| protein_bound = Unknown
| metabolism = [[Liver|Hepatic]]
| elimination_half-life = Unknown
| excretion = 
| pregnancy_AU =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =  
| legal_AU =  <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_CA =  <!--                             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK =  <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US =  <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status = 
| routes_of_administration = Oral
}}
'''Octatropine methylbromide''' ([[International Nonproprietary Name|INN]]) or '''anisotropine methylbromide''' ([[United States Adopted Name|USAN]]), trade names '''Valpin''', '''Endovalpin''', '''Lytispasm''' and others,<ref name=DPA>{{cite book |author=David J. Triggle |author2=C. R. Ganellin |author3=F. MacDonald  |title=Dictionary of Pharmacological Agents |publisher=Chapman & Hall/CRC |location=Boca Raton |year=1997 |volume=2 |pages=1467 |isbn=0-412-46630-9 |url=https://books.google.com/books?id=A0THacd46ZsC}} Retrieved on August 31, 2008 through [[Google Book Search]].</ref> is a [[muscarinic antagonist]] and [[antispasmodic]]. It was introduced to the U.S. market in 1963 as an adjunct in the treatment of [[peptic ulcer]],<ref>{{cite journal |vauthors=Batterman RC, Mouratoff GJ, Kaufman JE |title=Anisotropine methylbromide: a new antispasmodic for gastrointestinal disorders |journal=Curr Ther Res Clin Exp |volume=5 |issue= |pages=213–8 |date=May 1963 |pmid=13966843 |doi= |url=}}</ref> and promoted as being more specific to the [[gastrointestinal tract]] than other anticholinergics, although its selectivity was questioned in later studies.<ref>{{cite book |author=Gyermek, Laszlo |title=Pharmacology of antimuscarinic agents |publisher=CRC Press |location=Boca Raton |year=1998 |pages=183 |isbn=0-8493-8559-8 |oclc= |url=https://books.google.com/books?id=_VyDxfdunv4C&pg=PA183&dq=anisotropine}} Retrieved on August 31, 2008 through Google Book Search.</ref><ref>{{cite journal |author=Bachrach WH |title=Clinical evaluation of anisotropine methyl bromide (valpin), an anticholinergic drug |journal=Am J Dig Dis |volume=17 |issue=6 |pages=505–12 |date=June 1972 |pmid=4555460 |doi=10.1007/BF02231205}}</ref>

Octatropine has been superseded by more effective agents in the treatment of peptic ulcer disease, and is no longer used. It is still sold in some countries in combination with other drugs, such as [[phenobarbital]] and [[metamizole]].

==References==
{{Reflist}}

{{Drugs for functional gastrointestinal disorders}}
{{Muscarinic acetylcholine receptor modulators}}

[[Category:Muscarinic antagonists]]
[[Category:Tropanes]]
[[Category:Carboxylate esters]]
[[Category:Quaternary ammonium compounds]]


{{gastrointestinal-drug-stub}}